Physician profile
Morris Eugene Kelley
NPI 1104939636
$9,702.02
in general payments reported to CMS, 2019-2025
36 companies · $1,109 in 2025
The $1,109 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,505 · 2020: $982 · 2021: $1,379 · 2022: $1,061 · 2023: $1,302 · 2024: $1,364 · 2025: $1,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,774.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,575.93 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,041.54 | 2019-2025 | Farxiga, Andexxa |
| Janssen Pharmaceuticals, INC | $696.13 | 2019-2023 | Xarelto |
| Boston Scientific Corporation | $669.79 | 2019-2025 | Ekosonic, Eluvia, Watchman |
| Abiomed | $654.82 | 2019-2025 | |
| Amgen INC. | $574.40 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $534.30 | 2019-2025 | Jardiance |
| Pfizer INC. | $511.35 | 2019-2025 | |
| Irhythm Technologies, INC. | $458.31 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Shockwave Medical, INC | $448.13 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $340.54 | 2019-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $310.89 | 2019-2024 | |
| Esperion Therapeutics, INC. | $277.20 | 2020-2023 | Nexletol |
| Alnylam Pharmaceuticals INC. | $253.92 | 2022-2025 | Amvuttra, Onpattro |
| Merck Sharp & Dohme LLC | $192.58 | 2021-2025 | Verquvo |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $169.65 | 2019-2021 | |
| Astellas Pharma US INC | $142.20 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $111.04 | 2019-2025 | Camzyos |
| Baxter Healthcare | $91.13 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $73.23 | 2021-2025 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals International, Plc | $65.24 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $64.48 | 2023-2025 | |
| Abbott Laboratories | $63.09 | 2020-2021 | |
| Cardiovascular Systems INC. | $49.59 | 2019-2022 | |
| Medtronic Vascular, INC. | $48.60 | 2019 | |
| Inari Medical, INC. | $39.93 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lundbeck LLC | $39.89 | 2019 | |
| Gilead Sciences, INC. | $37.66 | 2019 | |
| Philips North America LLC | $34.28 | 2020-2022 | |
| Innovation Technologies INC | $29.52 | 2025 | Irrisept |
| Medtronic, INC. | $19.57 | 2025 | Micra |
| Bard Peripheral Vascular, INC. | $18.74 | 2025 | Rotarexs 6 F X 135 Cm |
| Lexicon Pharmaceuticals, INC. | $18.15 | 2024 | |
| Bridgebio Pharma, INC. | $16.79 | 2025 | Attruby |
| Cardiva Medical, INC. | $15.51 | 2024 | Cardiva Vascade 5f Vcs |
| Tactile Systems Technology INC | $13.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morris Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.